| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/02/2000 | EP1047414A1 Gabapentin and its derivatives for the treatment of muscular and skeletal pain |
| 11/02/2000 | EP1047413A1 Pharmazeutische zusammenstellung |
| 11/02/2000 | EP1047412A1 New use of local anaesthetics against vascular headaches |
| 11/02/2000 | EP1047411A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 11/02/2000 | EP1047410A1 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists |
| 11/02/2000 | EP1047409A1 Tts containing an antioxidant |
| 11/02/2000 | EP1047406A1 Autoclavable pharmaceutical compositions containing a chelating agent |
| 11/02/2000 | EP1047399A1 Skin care composition |
| 11/02/2000 | EP1047398A1 Topical compositions containing whey proteins |
| 11/02/2000 | EP1047397A1 Topical compositions for enhancing glutathione production |
| 11/02/2000 | EP1047394A1 Low-ph, acid-containing personal care compositions which exhibit reduced sting |
| 11/02/2000 | EP0914331B1 Neuroactive peptides |
| 11/02/2000 | EP0888316B1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors |
| 11/02/2000 | EP0853619B1 Disubstituted piperidine derivatives |
| 11/02/2000 | EP0853485A4 Therapeutic administration of hemoglobin in cardiac arrest |
| 11/02/2000 | EP0848592B1 Antistress agents for aquatic animals |
| 11/02/2000 | EP0808312B1 Indole derivatives as 5-ht receptor antagonist |
| 11/02/2000 | EP0774963B1 Pharmaceutically stable oxaliplatinum preparation |
| 11/02/2000 | EP0766679A4 Bioactive acetogenins and derivatives |
| 11/02/2000 | EP0626844B1 Compositions of clindamycin and benzoyl peroxide for acne treatment |
| 11/02/2000 | DE19919828A1 Treating male or female sexual dysfunction, especially erectile dysfunction, using propentofylline or corresponding alcohol as selective phosphodiesterase V inhibitor |
| 11/02/2000 | DE19919793A1 Neue Sulfonamide New sulfonamides |
| 11/02/2000 | DE19919481A1 Stabile, gegen unreine Haut und gegen Akne wirksame Wirkstoffkombinationen mit einem Gehalt an grenzflächenaktiven Glucosederivaten und Hydroxycarbonsäuren Stable, effective against blemished skin and acne drug combinations containing surface-active glucose derivatives and hydroxycarboxylic |
| 11/02/2000 | DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk |
| 11/02/2000 | CA2372154A1 Process of purifying phytosterols from wood or plant-derived sources and compositions resulting therefrom |
| 11/02/2000 | CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands |
| 11/02/2000 | CA2371274A1 Selective npy (y5) antagonists |
| 11/02/2000 | CA2371242A1 Diagnosis of human kidney diseases |
| 11/02/2000 | CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor |
| 11/02/2000 | CA2371217A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| 11/02/2000 | CA2371165A1 Vitamin d analogues and their pharmaceutical use |
| 11/02/2000 | CA2371114A1 Death domain containing receptors |
| 11/02/2000 | CA2371064A1 Methods of delivery of cetyl myristoleate |
| 11/02/2000 | CA2371055A1 Compositions and methods for improving insulin sensitivity and glucose metabolism in mammals |
| 11/02/2000 | CA2371046A1 Therapeutic compositions and methods for enhancing angiogenesis |
| 11/02/2000 | CA2370653A1 Pharmaceutical compositions of tetrac and methods of use thereof |
| 11/02/2000 | CA2370643A1 Noscapine derivatives as adjuvant compositions and methods of use thereof |
| 11/02/2000 | CA2370639A1 Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy |
| 11/02/2000 | CA2370607A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method |
| 11/02/2000 | CA2370600A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity |
| 11/02/2000 | CA2370592A1 Percutaneous absorption preparations containing oxybutynin |
| 11/02/2000 | CA2370590A1 Agent for suppressing the odors of sulfides formed through fermentation in the large intestine |
| 11/02/2000 | CA2370581A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives |
| 11/02/2000 | CA2370576A1 Novel anticoagulant injectable composition |
| 11/02/2000 | CA2370553A1 Cardiovascular and bone treatment using isoflavones |
| 11/02/2000 | CA2370387A1 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same |
| 11/02/2000 | CA2370280A1 Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt |
| 11/02/2000 | CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 11/02/2000 | CA2370262A1 Thiazolidinedione derivative and its use as antidiabetic |
| 11/02/2000 | CA2370258A1 Thiazolidinedione derivative and its use as antidiabetic |
| 11/02/2000 | CA2370241A1 Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression |
| 11/02/2000 | CA2370195A1 Human membrane-associated proteins |
| 11/02/2000 | CA2370043A1 Liposome bonded with antibody and polyalkylene glycol |
| 11/02/2000 | CA2369951A1 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers |
| 11/02/2000 | CA2369942A1 Use of n-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients |
| 11/02/2000 | CA2369910A1 Compositions and methods for treatment of hyperproliferative diseases |
| 11/02/2000 | CA2369740A1 Long term administration of pharmacologically active agents |
| 11/02/2000 | CA2369552A1 Agent for prophylaxis and treatment of angiostenosis |
| 11/02/2000 | CA2369109A1 Thrombin inhibitors |
| 11/02/2000 | CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 11/02/2000 | CA2368205A1 N-protected amines and their use as prodrugs |
| 11/02/2000 | CA2367980A1 Complete feed for fish larvae and method for preparing same |
| 11/02/2000 | CA2367695A1 Heteroaryl diazacycloalkanes, their preparation and use |
| 11/02/2000 | CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 11/02/2000 | CA2367681A1 Azaindole derivatives for the treatment of depression |
| 11/01/2000 | CN1272139A Nucleic acids coding for proteins capable of interacting with presenilins |
| 11/01/2000 | CN1272113A Lyxofuranosyl benzimidazoles as antiviral agents |
| 11/01/2000 | CN1272112A Process for acylation of amino alcohols |
| 11/01/2000 | CN1272111A Tricyclic vasopressin agonists |
| 11/01/2000 | CN1272110A Tricyclic vasopressin agonists |
| 11/01/2000 | CN1272109A Process for producing isooxazolidinedione compound |
| 11/01/2000 | CN1272108A Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 11/01/2000 | CN1272107A Benzamidine derivatives as factor Xa inhibitors |
| 11/01/2000 | CN1272105A Compound containing six-membered rings, processes for their preparation, and their use as medicaments |
| 11/01/2000 | CN1272063A Prostaglandin product |
| 11/01/2000 | CN1272060A Use of sulfated oligosaccharides as inhibitors of cardiovascular disease |
| 11/01/2000 | CN1272059A Carotenoid formulation |
| 11/01/2000 | CN1272043A Nutritional composition for treatment of pressure ulcers |
| 11/01/2000 | CN1271737A Process for preparing amylovorin of sea bacteria and its application |
| 11/01/2000 | CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition |
| 11/01/2000 | CN1271733A CpG oligonucleotide with specific immunostimulation activity to human immune cell |
| 11/01/2000 | CN1271731A New thiazole benzimidazole derivative |
| 11/01/2000 | CN1271724A (2-substituted oxyphenyl) alkane acylamide derivative and hair nourishing agent, skin external use agent |
| 11/01/2000 | CN1271592A Health-care oil for reducing cholesterol and its preparing process |
| 11/01/2000 | CN1271588A Medicine for treating myopia |
| 11/01/2000 | CN1271587A Medicine for treating skin ulcer |
| 11/01/2000 | CN1271581A Nutritive composite bio-chemical health-care products |
| 11/01/2000 | CN1271580A Medicine for treating and preventing saturnism and its preparing process |
| 11/01/2000 | CN1271579A Compound vitamin for health of cardiovascular |
| 11/01/2000 | CN1271578A Soluble disinfecting condom |
| 11/01/2000 | CN1271577A Medicine preparation and its use and the use of high grade primary alcohol mixture |
| 11/01/2000 | CN1271570A Cosmetic composition containing pigment originated from pyrolopyrrole |
| 11/01/2000 | CN1058018C Androsterone derivatives and its preparing process |
| 11/01/2000 | CN1058017C Intermediate for prepariny etoposide |
| 11/01/2000 | CN1058016C Sulphuric acid esters of amino-sugars, its salt for medicine, preparing process and use |
| 11/01/2000 | CN1058014C New heterocyclic spiro compounds, process for preparation thereof, and pharmaceutical compositions containing them |
| 11/01/2000 | CN1058013C Process for preparation of novel mercaptoacetylamide derivatives |
| 11/01/2000 | CN1058010C Novel quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime) pyrrolidine substituent and process for preparing thereof |
| 11/01/2000 | CN1058009C 8-oxy-5,8-dihydro-6H-dibenzo [a,g] quinolizine -13-propionic acid derivant, its preparation method and medicinal use thereof |
| 11/01/2000 | CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors |